RxDoctor Payments Data

Luther Oakes, MD

Interventional Pain Medicine · Greenville, MSNPI 1215167150

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.6% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Merz North America, Inc. at 51.0% of the total. Reporting peaked in 2022 at $987 and has fallen 86.5% since, to $133 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in MS, where the typical reported total is $2,720.

$1,970in general payments, 2019–2025

Across 39 payments — averaging $50.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$1K
  • Medtronic$353
  • Boston Scientific$250
  • Abbott$111
  • Pfizer$67
  • Interventional Pain Technologies Inc.$39
  • plus $144 from 6 others

What the payments were for

  • Travel & lodging$1256%
  • Food & beverage$1,84594%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Merz North America, Inc.3$1,006
Medtronic12$353
Boston Scientific4$250
Abbott5$111
Pfizer5$67
Interventional Pain Technologies Inc.1$39
Boehringer Ingelheim2$37
AbbVie2$34
Lilly USA, LLC2$29
Forte Bio-pharma LLC1$15
Johnson & Johnson1$15
Amgen1$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,970 in reported general payments places this provider in the 35th percentile of 24 interventional pain medicine providers in Mississippi.

See all interventional pain medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$441,947
Medicare patients
259
Services billed
7,840

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,402$27,940
OxycontinOxycodone Hcl11$23,481
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen627$15,778
Fentanyl59$7,855
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl21$4,505
Gabapentin337$3,463
Pregabalin213$2,636
Diclofenac Sodium103$2,539
Morphine Sulfate ErMorphine Sulfate72$2,474
Oxycodone Hcl153$2,392
Acetaminophen-CodeineAcetaminophen With Codeine57$1,565
Tizanidine Hcl132$1,192
Cyclobenzaprine Hcl110$1,173
Morphine Sulfate42$1,103
Tramadol Hcl119$999

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Greenville

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →